Levocetirizine Di-Hydrochloride Prices Remain Northward Globally
- 16-Feb-2023 3:42 PM
- Journalist: Nicholas Seifield
Levocetirizine Di-Hydrochloride followed an upward price trajectory in February 2023 across the globe due to a consistent surge in end-user demand and higher input prices. Moreover, ease in inflation, freight charges, and dip in energy costs further support the current price trend for the product across the globe, including Germany, China, and the United States, as consumer confidence in Levocetirizine Di-Hydrochloride improved.
Following the Chinese market's reopening, factory and port operations got underway, and as a result of the increased production, Active Pharmaceutical Ingredients (APIs) prices in the Chinese market have increased. The demand expectation for Levocetirizine Di-Hydrochloride, one of the end-user industries' APIs, supported the increased supply within the domestic and overseas markets. Additionally, the increase in container logistics indicates that the trend of decline has stopped, which is promising for many industry players in the pharmaceutical industry as traders consistently place newer quotations for their end-product Levocetirizine Di-Hydrochloride in order to prevent a further shortage. Overall, the price of Levocetirizine Di-Hydrochloride increased in January 2023 and shadows a similar trend in February 2023. Moreover, after the Chinese New Year holiday, bulk demand from the end-user pharmaceutical sector, as drugmakers, resumed their operations for API.
Moreover, Germany and the United States witness a sturdy price trend for Levocetirizine Di-Hydrochloride. Ease in trade disruption from export nations and costly imports from the APAC region reinforced this price trend during February 2023. Traders and retailers focused on stocking their inventories for Levocetirizine Di-Hydrochloride because of a significant improvement in customer inquiries for this API's weaker stocks. Overall, Germany is likely to show an increment of around 0.6 percent in the prices of Levocetirizine Di-Hydrochloride, and the USA of around 0.46 percent during the mid of Q1-2023, respectively.
ChemAnalyst analysis that "the cost of Levocetirizine Di-Hydrochloride anticipates a positive trend in the upcoming months as well. Demand from the downstream sector might rise at a moderate rate. Traders and retailers will likely focus on raising their stocks for Levocetirizine Di-Hydrochloride to cater to the overall inquiries within the domestic and international markets.